Kaymaz-Tahra, S. Et Al. 2023. Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis.. 2023 ACR/ARHP Annual Meeting , (San Diego, United States Of America).

Kaymaz-Tahra, S., Bayındır, Ö., İNCE, B., ÖZDEMİR IŞIK, Ö., KUTU, M. E., KARAKAŞ, Ö., ... DEMİRCİ YILDIRIM, T.(2023). Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis. . 2023 ACR/ARHP Annual Meeting, San Diego, United States Of America

Kaymaz-Tahra, Sema Et Al. "Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis.," 2023 ACR/ARHP Annual Meeting, San Diego, United States Of America, 2023

Kaymaz-Tahra, Sema Et Al. "Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis.." 2023 ACR/ARHP Annual Meeting , San Diego, United States Of America, 2023

Kaymaz-Tahra, S. Et Al. (2023) . "Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis.." 2023 ACR/ARHP Annual Meeting , San Diego, United States Of America.

@conferencepaper{conferencepaper, author={Sema Kaymaz-Tahra Et Al. }, title={Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis.}, congress name={2023 ACR/ARHP Annual Meeting}, city={San Diego}, country={United States Of America}, year={2023}}